NCT03841188

Brief Summary

BACKGROUND: In several bone disorders, adequate calcium intake is a coadjuvant intervention to regular treatment. Osteogenesis imperfecta (OI) is a collagen disorder with a range of symptoms, ranging from fractures to minimum trauma, and is typically treated with bisphosphonates. This study aims evaluate the impact of a nutritional intervention (NI) on dietary calcium intake, bone mineral density (BMD)in pediatric patients with OI. METHODS: Interventional cohort study was designed with a NI. Dietary calcium intake, anthropometry and clinical feature was assessed at baseline including anthropometry, basal metabolic rate (BMR), BMD, Food guidance form was developed and sent to patients by mail. After 12 months, patients' clinical features were reassessed and compared with baseline data. RESULTS: Fifty-two children and adolescents were enrolled. A significant increase in total calcium intake (g), the percentage of adequate calcium intake (%), number of cups of milk ingested, were observed after NI. Was detected a positive correlation between the variation of BMD and milk consumption in patients treated with bisphosphonate. CONCLUSION: Was observed an increase in calcium intake in patients with OI. This finding demonstrates the importance of nutrition therapy as part of a multidisciplinary treatment approach for bone health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2013

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2014

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
Last Updated

February 19, 2019

Status Verified

January 1, 2019

Enrollment Period

1.3 years

First QC Date

February 13, 2019

Last Update Submit

February 15, 2019

Conditions

Keywords

osteogenesis imperfectaNutritional interventioncalcium intake

Outcome Measures

Primary Outcomes (1)

  • Calcium intake

    Was assessed using an food frequency questionaire adapted to calcium intake

    12 months

Secondary Outcomes (3)

  • Consumption of glasses of milk

    12 months

  • Body mass index

    12 months

  • Bone Mineral Density

    12 months

Study Arms (1)

Nutritional Orientation

OTHER

The patients received a nutritional orientation with emphasis in food rich in calcium

Other: Nutritional orientation

Interventions

Nutritional orientation with emphasis in rich calcium food

Nutritional Orientation

Eligibility Criteria

AgeUp to 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients from zero to 19 years of patients seen at hospital.
  • Diagnosed with osteogenesis imperfecta

You may not qualify if:

  • \- Diagnosed with bone disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-007, Brazil

Location

MeSH Terms

Conditions

Osteogenesis Imperfecta

Condition Hierarchy (Ancestors)

OsteochondrodysplasiasBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Elza D Mello, MD, PhD

    Hospital de Clinicas de Porto Alegre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2019

First Posted

February 15, 2019

Study Start

February 8, 2012

Primary Completion

May 20, 2013

Study Completion

February 10, 2014

Last Updated

February 19, 2019

Record last verified: 2019-01

Locations